NCT05138094

LIVACOR Trial: Minimally Invasive LIVer And Simultaneous COlorectal Resection

• Status: Unknown
• Phase: N/A
• Study type: Interventional
• Enrollment: 82 (estimated)
• Sponsor: Fondazione Poliambulanza Istituto Ospedaliero · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The LIVACOR - Trial is a European wide, randomized controlled, open-label, multicenter trial. Patients with synchronous colorectal liver metastases (CRLMs) and primary colorectal tumor are considered eligible and will be randomized between minimally invasive (MI) combined or staged colorectal resection (all colectomies, including high anterior resection) and liver resection of up to three segments.

Conditions

• Colorectal Neoplasms Malignant
• Neoplasm Metastasis

Interventions

Type	Name	Description
PROCEDURE	Minimally invasive simultaneous resection	One minimally invasive surgical procedure wherein both the primary colorectal carcinoma and the liver metastases are removed.
PROCEDURE	Minimally invasive two-stage resection	Two minimally invasive surgical procedures wherein the primary colorectal carcinoma and the liver metastases are removed

Timeline

• Start date: 2021-08-06
• Primary completion: 2023-09-01
• Completion: 2024-09-01
• First posted: 2021-11-30
• Last updated: 2022-07-25

Locations

28 sites across 10 countries: Belgium, France, Germany, Italy, Luxembourg, Netherlands, Norway, Russia, Spain, United Kingdom